another.vc — 2026 Investments
2 investments dated 2026 · listed companies and verified rows first · show all
Immitra Bio develops an in-vivo stem cell therapy platform designed to treat rare genetic diseases, particularly severe inherited red blood cell disorders, by replacing complex transplants with single off-the-shelf treatments.
BiotechDeep TechMedical DevicesZürich, CH
Co-investorsKickfundOCCIDENTBackbone VenturesVenture Kick
ARK offers software for German municipalities to plan, track, and publicly display climate protection measures across departments, including BISKO-compliant greenhouse gas accounting without external consultants.
Climate TechGovTechSaaS
Co-investorsSatgana
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.